AlphaYouJG
Congress trade
Rep. Josh Gottheimer (D-NJ) sold $1K-$15K of DexCom, Inc. (DXCM) stock
Josh Gottheimer, U.S. Representative (D-NJ), disclosed a sale of DexCom, Inc. (DXCM) stock worth $1K-$15K in a STOCK Act filing on Oct 16, 2022.
The trade happened on Sep 28, 2022, 18 days before it was made public.
DXCM has moved +2.4% since the trade date, from $83.33 to $85.36 (Oct 2, 2026 close).
- Traded
- Sep 28, 2022
- Disclosed
- Oct 16, 2022
- Filing delay
- 18 days
- Price since
- +2.4%
- Source
- STOCK Act disclosure
Other trades in this disclosure (24)
- SellABMD$1K-$15KOct 16, 2022
- BuyADP$1K-$15KOct 16, 2022
- BuyALNY$1K-$15KOct 16, 2022
- SellBHP$1K-$15KOct 16, 2022
- SellBX$1K-$15KOct 16, 2022
- SellCRM$1K-$15KOct 16, 2022
- SellCTSH$1K-$15KOct 16, 2022
- SellCVET$1K-$15KOct 16, 2022
- SellDE$1K-$15KOct 16, 2022
- SellFIS$1K-$15KOct 16, 2022
- BuyFLYW$1K-$15KOct 16, 2022
- SellHCA$1K-$15KOct 16, 2022
- SellMDB$1K-$15KOct 16, 2022
- SellMGY$1K-$15KOct 16, 2022
- SellNVDA$1K-$15KOct 16, 2022
- SellORCL$1K-$15KOct 16, 2022
- SellPCTY$1K-$15KOct 16, 2022
- BuyREGN$1K-$15KOct 16, 2022
- SellSAP$1K-$15KOct 16, 2022
- BuySTAG$1K-$15KOct 16, 2022
More DXCM insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.